News Detail

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 04/29 17:06

Listen to the news

Gainers

LogicMark (NASDAQ:LGMK) shares rose 50.4% to $0.02 during Tuesday's regular session.
Kala Bio (NASDAQ:KALA) stock rose 39.13% to $4.97. The market value of their outstanding shares is at $30.2 million.
ENDRA Life Sciences (NASDAQ:NDRA) shares increased by 33.48% to $5.74. The market value of their outstanding shares is at $3.0 million.
LifeMD (NASDAQ:LFMD) shares moved upwards by 32.78% to $8.1. The market value of their outstanding shares is at $361.1 million.
iBio (NASDAQ:IBIO) shares increased by 27.14% to $1.33. The market value of their outstanding shares is at $13.1 million.
Hims & Hers Health (NYSE:HIMS) stock rose 26.12% to $35.92. The company's market cap stands at $8.0 billion.

Losers

Petros Pharma (NASDAQ:PTPI) stock decreased by 71.0% to $0.02 during Tuesday's regular session.
Zhengye Biotechnology (NASDAQ:ZYBT) shares decreased by 34.63% to $9.25. The company's market cap stands at $438.3 million.
NeoGenomics (NASDAQ:NEO) stock declined by 31.9% to $6.79. The market value of their outstanding shares is at $872.2 million. The company's, Q1 earnings came out today.
Tivic Health Systems (NASDAQ:TIVC) stock decreased by 25.2% to $4.84. The company's market cap stands at $2.9 million.
Universe Pharmaceuticals (NASDAQ:UPC) stock declined by 23.37% to $4.56. The company's market cap stands at $69.4 million.
Relmada Therapeutics (NASDAQ:RLMD) stock fell 15.99% to $0.3. The company's market cap stands at $9.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.